[Form 4] GoodRx Holdings, Inc. Insider Trading Activity
On 08/08/2025 Nabiey Romin, Chief Accounting Officer of GoodRx Holdings, Inc. (GDRX), reported the vesting of 12,663 restricted stock units (RSUs) and a disposition of 4,531 Class A common shares at a price of $3.47 per share. The Form 4 is signed by Gracye Cheng, Attorney-in-Fact, dated 08/08/2025.
The filing shows beneficial ownership following these transactions of 134,207 Class A shares (direct) and 88,639 derivative securities reported as direct holdings. The RSU disclosure states each unit equals one share, with 6.25% vested on August 8, 2023 and the remaining 93.75% vesting in equal quarterly installments over 15 quarters.
Il 08/08/2025 Nabiey Romin, Chief Accounting Officer di GoodRx Holdings, Inc. (GDRX), ha riportato il vesting di 12,663 restricted stock units (RSU) e la cessione di 4,531 azioni ordinarie di Classe A al prezzo di $3.47 per azione. Il Form 4 猫 firmato da Gracye Cheng, procuratore, in data 08/08/2025.
La comunicazione indica, a seguito di queste operazioni, una partecipazione beneficiaria di 134,207 azioni di Classe A (dirette) e 88,639 strumenti derivati riportati come detenzioni dirette. La nota sulle RSU specifica che ogni unit脿 equivale a una azione, con 6,25% maturato l'8 agosto 2023 e il restante 93,75% che matura in rate trimestrali uguali per 15 trimestri.
El 08/08/2025 Nabiey Romin, Chief Accounting Officer de GoodRx Holdings, Inc. (GDRX), inform贸 el vesting de 12,663 unidades de acciones restringidas (RSU) y la enajenaci贸n de 4,531 acciones Clase A a un precio de $3.47 por acci贸n. El Form 4 est谩 firmado por Gracye Cheng, apoderada, con fecha 08/08/2025.
La presentaci贸n muestra una participaci贸n beneficiaria tras estas operaciones de 134,207 acciones Clase A (directas) y 88,639 valores derivados declarados como tenencias directas. La divulgaci贸n de las RSU indica que cada unidad equivale a una acci贸n, con 6,25% consolidado el 8 de agosto de 2023 y el 93,75% restante que se consolida en cuotas trimestrales iguales durante 15 trimestres.
2025雲� 8鞗� 8鞚�, GoodRx Holdings, Inc.(GDRX)鞚� 斓滉碃須岅硠毂呾瀯鞛�(CAO)鞚� Nabiey Romin鞚� 12,663臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)臧� 氩犾姢韺呺悩鞐堦碃, 4,531欤检潣 韥措灅鞀� A 氤错喌欤�臧� 欤茧嫻 $3.47鞐� 觳橂秳霅橃棃雼り碃 氤搓碃頄堨姷雼堧嫟. 頃措嫻 Form 4 氍胳劀電� 雽�毽澑 Gracye Cheng鞚� 2025雲� 8鞗� 8鞚检瀽搿� 靹滊獏頄堨姷雼堧嫟.
鞚措矆 瓯半灅 鞚错泟 氤搓碃靹滌棎電� 歆侅爲 氤挫湢 134,207欤� 韥措灅鞀� A鞕赌 歆侅爲 氤挫湢搿� 鞁犼碃霅� 88,639臧滌潣 韺岇儩歃濌秾 靾橁皜 旮办灛霅橃柎 鞛堨姷雼堧嫟. RSU 瓿奠嫓鞐愳劀電� 臧� 雼渼臧� 1欤检櫠� 霃欖澕頃橂┌, 6.25%電� 2023雲� 8鞗� 8鞚检棎 氩犾姢韺呺悩鞐堦碃 雮橂ǜ歆赌 93.75%電� 15攵勱赴鞐� 瓯胳硱 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 氩犾姢韺呺悳雼�瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
Le 08/08/2025, Nabiey Romin, Chief Accounting Officer de GoodRx Holdings, Inc. (GDRX), a d茅clar茅 le vesting de 12 663 unit茅s d'actions restreintes (RSU) et la cession de 4 531 actions de cat茅gorie A 脿 un prix de 3,47 $ par action. Le Form 4 est sign茅 par Gracye Cheng, mandataire, en date du 08/08/2025.
Le d茅p么t indique, apr猫s ces op茅rations, une d茅tention b茅n茅ficiaire de 134 207 actions de cat茅gorie A (directes) et 88 639 titres d茅riv茅s d茅clar茅s comme participations directes. La mention relative aux RSU pr茅cise qu'une unit茅 茅quivaut 脿 une action, avec 6,25 % acquis le 8 ao没t 2023 et les 93,75 % restants devant 锚tre acquis par versements trimestriels 茅gaux sur 15 trimestres.
Am 08.08.2025 meldete Nabiey Romin, Chief Accounting Officer von GoodRx Holdings, Inc. (GDRX), das Vesting von 12,663 Restricted Stock Units (RSU) und die Ver盲u脽erung von 4,531 Class鈥慉鈥慡tammaktien zu einem Preis von $3,47 pro Aktie. Das Form 4 ist von Gracye Cheng als Bevollm盲chtigte am 08.08.2025 unterzeichnet.
Die Einreichung weist nach diesen Transaktionen eine wirtschaftliche Beteiligung von 134,207 Class鈥慉鈥慉ktien (direkt) und 88,639 derivativen Wertpapieren aus, die als direkte Best盲nde gemeldet sind. Die RSU鈥慉ngabe besagt, dass jede Einheit einer Aktie entspricht, wobei 6,25% am 8. August 2023 f盲llig wurden und die verbleibenden 93,75% in gleichen viertelj盲hrlichen Raten 眉ber 15 Quartale vesten.
- On 08/08/2025, 12,663 restricted stock units vested, representing a clear equity-compensation event disclosed on the Form 4.
- The filing is properly executed and signed by Gracye Cheng, Attorney-in-Fact, meeting signature disclosure requirements.
- On 08/08/2025, 4,531 Class A shares were disposed at a price of $3.47, reducing direct reported holdings.
- The RSU schedule shows 93.75% of the granted RSUs remain to vest in equal quarterly installments over 15 quarters, indicating ongoing potential dilution until fully vested.
Insights
TL;DR: Routine equity-compensation vesting and a small sale reported; no material change to disclosed insider ownership levels.
The Form 4 documents an equity-compensation event and a subsequent disposition on 08/08/2025. Specifically, 12,663 RSUs vested and 4,531 Class A shares were disposed at $3.47 per share. Post-transaction beneficial ownership is reported as 134,207 Class A shares and 88,639 derivative securities held directly. Given the information provided, these entries reflect regular vesting and a limited sale; the filing does not disclose other material corporate events or financial metrics.
TL;DR: Form 4 properly discloses insider vesting schedule and a disposal; filing is consistent with Section 16 reporting requirements.
The report identifies Nabiey Romin as the reporting person and Chief Accounting Officer, and it documents the nature and amounts of equity-related transactions on 08/08/2025. The RSU vesting schedule is explicitly stated: each RSU equals one share, with an initial 6.25% vesting on August 8, 2023 and the remainder vesting quarterly over 15 quarters. The form is signed by an Attorney-in-Fact, which is a permitted signature method under Form 4 procedures. No governance issues or regulatory disclosures beyond the transactions are included in this filing.
Il 08/08/2025 Nabiey Romin, Chief Accounting Officer di GoodRx Holdings, Inc. (GDRX), ha riportato il vesting di 12,663 restricted stock units (RSU) e la cessione di 4,531 azioni ordinarie di Classe A al prezzo di $3.47 per azione. Il Form 4 猫 firmato da Gracye Cheng, procuratore, in data 08/08/2025.
La comunicazione indica, a seguito di queste operazioni, una partecipazione beneficiaria di 134,207 azioni di Classe A (dirette) e 88,639 strumenti derivati riportati come detenzioni dirette. La nota sulle RSU specifica che ogni unit脿 equivale a una azione, con 6,25% maturato l'8 agosto 2023 e il restante 93,75% che matura in rate trimestrali uguali per 15 trimestri.
El 08/08/2025 Nabiey Romin, Chief Accounting Officer de GoodRx Holdings, Inc. (GDRX), inform贸 el vesting de 12,663 unidades de acciones restringidas (RSU) y la enajenaci贸n de 4,531 acciones Clase A a un precio de $3.47 por acci贸n. El Form 4 est谩 firmado por Gracye Cheng, apoderada, con fecha 08/08/2025.
La presentaci贸n muestra una participaci贸n beneficiaria tras estas operaciones de 134,207 acciones Clase A (directas) y 88,639 valores derivados declarados como tenencias directas. La divulgaci贸n de las RSU indica que cada unidad equivale a una acci贸n, con 6,25% consolidado el 8 de agosto de 2023 y el 93,75% restante que se consolida en cuotas trimestrales iguales durante 15 trimestres.
2025雲� 8鞗� 8鞚�, GoodRx Holdings, Inc.(GDRX)鞚� 斓滉碃須岅硠毂呾瀯鞛�(CAO)鞚� Nabiey Romin鞚� 12,663臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)臧� 氩犾姢韺呺悩鞐堦碃, 4,531欤检潣 韥措灅鞀� A 氤错喌欤�臧� 欤茧嫻 $3.47鞐� 觳橂秳霅橃棃雼り碃 氤搓碃頄堨姷雼堧嫟. 頃措嫻 Form 4 氍胳劀電� 雽�毽澑 Gracye Cheng鞚� 2025雲� 8鞗� 8鞚检瀽搿� 靹滊獏頄堨姷雼堧嫟.
鞚措矆 瓯半灅 鞚错泟 氤搓碃靹滌棎電� 歆侅爲 氤挫湢 134,207欤� 韥措灅鞀� A鞕赌 歆侅爲 氤挫湢搿� 鞁犼碃霅� 88,639臧滌潣 韺岇儩歃濌秾 靾橁皜 旮办灛霅橃柎 鞛堨姷雼堧嫟. RSU 瓿奠嫓鞐愳劀電� 臧� 雼渼臧� 1欤检櫠� 霃欖澕頃橂┌, 6.25%電� 2023雲� 8鞗� 8鞚检棎 氩犾姢韺呺悩鞐堦碃 雮橂ǜ歆赌 93.75%電� 15攵勱赴鞐� 瓯胳硱 霃欖澕頃� 攵勱赴氤� 攵勴暊搿� 氩犾姢韺呺悳雼�瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
Le 08/08/2025, Nabiey Romin, Chief Accounting Officer de GoodRx Holdings, Inc. (GDRX), a d茅clar茅 le vesting de 12 663 unit茅s d'actions restreintes (RSU) et la cession de 4 531 actions de cat茅gorie A 脿 un prix de 3,47 $ par action. Le Form 4 est sign茅 par Gracye Cheng, mandataire, en date du 08/08/2025.
Le d茅p么t indique, apr猫s ces op茅rations, une d茅tention b茅n茅ficiaire de 134 207 actions de cat茅gorie A (directes) et 88 639 titres d茅riv茅s d茅clar茅s comme participations directes. La mention relative aux RSU pr茅cise qu'une unit茅 茅quivaut 脿 une action, avec 6,25 % acquis le 8 ao没t 2023 et les 93,75 % restants devant 锚tre acquis par versements trimestriels 茅gaux sur 15 trimestres.
Am 08.08.2025 meldete Nabiey Romin, Chief Accounting Officer von GoodRx Holdings, Inc. (GDRX), das Vesting von 12,663 Restricted Stock Units (RSU) und die Ver盲u脽erung von 4,531 Class鈥慉鈥慡tammaktien zu einem Preis von $3,47 pro Aktie. Das Form 4 ist von Gracye Cheng als Bevollm盲chtigte am 08.08.2025 unterzeichnet.
Die Einreichung weist nach diesen Transaktionen eine wirtschaftliche Beteiligung von 134,207 Class鈥慉鈥慉ktien (direkt) und 88,639 derivativen Wertpapieren aus, die als direkte Best盲nde gemeldet sind. Die RSU鈥慉ngabe besagt, dass jede Einheit einer Aktie entspricht, wobei 6,25% am 8. August 2023 f盲llig wurden und die verbleibenden 93,75% in gleichen viertelj盲hrlichen Raten 眉ber 15 Quartale vesten.
FAQ
What transactions did Nabiey Romin report on Form 4 (GDRX)?
How many Class A shares does Nabiey Romin beneficially own after the reported transactions?
How many derivative securities (RSUs) are reported after the transaction?
What RSU vesting schedule is disclosed in the filing?
Who signed the Form 4 and when was it signed?
